The field of Alzheimer’s Disease (AD) treatment is undergoing a transformative phase with recent drug approvals demonstrating the ability to slow cognitive decline in the early stages of the disease. These advancements mark a promising shift toward disease modification and prevention. However, they also emphasize the need for early detection and present new challenges in designing and conducting future clinical trials for AD. As these treatments gain traction in the affected patient population, drug developers must adopt strategic approaches to ensure successful trial outcomes. In this webinar, the expert speakers will explore recent AD drug approvals, diagnostic criteria and methods for early detection and key operational considerations such as enrolling preclinical patients and evaluating how current treatments will impact future trial strategies.
Register for this webinar today to gain valuable insights that will help navigate the next chapter in AD treatment.
Speakers
Dr. Andreas Schreiner, MD, Senior Vice President, Medical Affairs, Neuroscience & Analgesia, Premier Research
Dr. Andreas Schreiner has considerable experience as a clinician, clinical researcher and investigator and brings more than 25 years of experience within the pharmaceutical industry and clinical research environment, having been involved in numerous global development programs. In his current role, he is responsible for providing strategic planning, coordination, knowledge and expertise in neuroscience and analgesia projects and/or standalone consultative services for development programs covering entire product lifecycles.
Dr. Schreiner is a board-certified psychiatrist and neurologist. He studied medicine at the Universities of Heidelberg and Mannheim, Germany, and completed residencies in the University Department of Neurology and in Psychiatry at the Central Institute of Mental Health, both in Mannheim, Germany.
Message Presenter
Chris Foster, PhD, Senior Project Manager, Neuroscience, Premier Research
Dr. Chris Foster has worked for more than 15 years in the basic and clinical research fields focused on aging, mild cognitive impairment and Alzheimer’s disease. He is responsible for managing clinical trials within the neuroscience division of Premier Research where he oversees the study life cycle and ensures clinical trials meet key metrics such as timelines and patient recruitment/retention goals. Dr. Foster received his PhD in Cognitive Neuroscience from the University of North Carolina at Chapel Hill.
Message PresenterWho Should Attend?
This webinar will benefit Managers and above at biotech and specialty pharma companies with job functions including, but not limited, to:
- Drug development
- Clinical operations
- Medical affairs
- Regulatory affairs
- Project management
What You Will Learn
Attendees will gain insights into:
- The evolving Alzheimer’s Disease treatment landscape
- Diagnostic criteria and early detection methods
- Patient enrollment considerations, including preclinical participants
- How recently approved drugs will impact the patient population and clinical trial design
Xtalks Partner
Premier Research
Premier Research, a global clinical research, product development, and consulting company, is dedicated to helping innovators transform life-changing ideas and breakthrough science into new medical treatments. We offer strategic solutions across the entire development lifecycle, from pre-clinical through commercialization, specializing in smart study design and full-service clinical trial management.
Leveraging technology and therapeutic expertise, we deliver clean, conclusive data with a focus on reducing development timelines, securing access to the right patients, and effectively navigating global regulations to ensure submission-ready results.
As an organization that puts patients first, we pride ourselves on helping customers answer the unmet needs of patients across a broad range of medical conditions. Visit premier-research.com.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account